Buys
Open market- Shares
- Avg price
- Total value
Daniel J. Lippis - CVP, TAVR at Edwards Lifesciences Corp
Issuer-level insider activity
- Role
- Cvp, Tavr
- Issuer ticker
- EW on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Daniel J. Lippis in Edwards Lifesciences Corp
Sells
Open market- Shares
- -8,992
- Avg price
- $84.57
- Total value
- -$760,487
Net
Past year- Shares
- -8,992
- Share %
- -100%
- Total value
- -$760,487
Reported holdings for Daniel J. Lippis in Edwards Lifesciences Corp
Form 4 holding
CVP, TAVR
Edwards Lifesciences Corp
- Security class
- Common Stock
- Shares / value
- 40,034
- Estimated value
- $3,671,109
- Report date
- 10 Jul 2026
- Price
- $91.70
- Ownership
- Direct
Form 4 holding
CVP, TAVR
Edwards Lifesciences Corp
- Security class
- Performance Rights
- Shares / value
- 7,850
- Estimated value
- Report date
- 07 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CVP, TAVR
Edwards Lifesciences Corp
- Security class
- Employee Stock Option (Right to Acquire)
- Shares / value
- 4,952
- Estimated value
- Report date
- 10 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Daniel J. Lippis in Edwards Lifesciences Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.